Annexon, Inc. (ANNX) stock
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.47−0.10 (-2.80%)
Close on Nov 17, 2026Market cap $709.42MP/E –Yield 0.00%
Annexon operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Annexon's operating cash flow for the twelve months ending Jun 30, 2026 was -$193.03M. For fiscal 2025 it was -$186.36M. The highest annual figure on record is -$28.36M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$186.36M | – |
| FY2024 | Dec 31, 2024 | -$118.01M | – |
| FY2023 | Dec 31, 2023 | -$121.14M | – |
| FY2022 | Dec 31, 2022 | -$116.31M | – |
| FY2021 | Dec 31, 2021 | -$106.11M | – |
| FY2020 | Dec 31, 2020 | -$53.09M | – |
| FY2019 | Dec 31, 2019 | -$28.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$48.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$46.80M | – |
| Q4 FY2025 | Dec 31, 2025 | -$45.93M | – |
| Q3 FY2025 | Sep 30, 2025 | -$52.30M | – |
| Q2 FY2025 | Jun 30, 2025 | -$38.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$50.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$36.02M | – |
| Q3 FY2024 | Sep 30, 2024 | -$32.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$21.71M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.48M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$36.38M | – |
| Q1 FY2023 | Mar 31, 2023 | -$32.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$27.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$30.72M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$30.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$28.32M | – |
| Q3 FY2021 | Sep 30, 2021 | -$29.72M | – |
| Q2 FY2021 | Jun 30, 2021 | -$24.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$23.44M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.79M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.87M | – |
See a number that looks wrong?